Medication info
Esomeprazole Magnesium Trihydrate 40mg Tablet

Esomeprazole Magnesium Trihydrate 40mg Tablet

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu×2)
Approval status
Active

MFDS item code 201905236 · Approved 2019.07.23 · Insurance code 654701990

Summary

Main use
Treatment of reflux and Zollinger-Ellison syndrome; prevention of ulcers and rebleeding; treatment of Helicobacter pylori infection and gastrointestinal symptoms caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water; do not chew or crush it. Administer 40 mg once daily. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Administer 20 mg once daily. Administer 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended for controlling subsequent symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Administer 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials of more than 4 weeks have not been conducted. Administer 20 mg once daily. The treatment period is 4∼8 weeks. Administer 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Administer with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Administer 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with the use of this medicine in children under 12 years of age.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of reflux and Zollinger-Ellison syndrome; prevention of ulcers and rebleeding; treatment of Helicobacter pylori infection and gastrointestinal symptoms caused by anti-inflammatory analgesics

  • Erosive reflux esophagitis
  • esophagitis
  • symptoms of gastroesophageal reflux disease
  • H. pylori positive duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • rebleeding.
View approved original text

This medication is effective for the treatment and symptom relief of gastroesophageal reflux disease (GERD) and erosive esophagitis. It is also used for the treatment and prevention of duodenal ulcers and peptic ulcers due to Helicobacter pylori infection. It helps to relieve upper gastrointestinal symptoms caused by NSAID use and treats gastric ulcers, and may also aid in the prevention of ulcers. It is applicable for the treatment of Zollinger-Ellison syndrome, and for maintenance therapy after preventing rebleeding in gastric and duodenal ulcers. It is effectively used for various gastrointestinal diseases and related symptoms.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water; do not chew or crush it. Administer 40 mg once daily. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Administer 20 mg once daily. Administer 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, as-needed administration is not recommended for controlling subsequent symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. Administer 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials of more than 4 weeks have not been conducted. Administer 20 mg once daily. The treatment period is 4∼8 weeks. Administer 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following intravenous induction to prevent rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Administer with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Administer 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years of age: There is no experience with the use of this medicine in children under 12 years of age.

Precautions

This medication should not be administered to certain patients. For example, patients with allergies or hypersensitivity to this drug or its components, those allergic to certain antibiotics, lactating women, and those with a history of heart disease should not take it. This medication may present multiple side effects. Common symptoms such as headaches, abdominal pain, diarrhea, and dizziness have been reported, as well as rare severe conditions including blood abnormalities, liver dysfunction, and serious skin reactions. Careful observation is necessary, especially if muscle pain or weakness is severe, as this may indicate a serious condition called rhabdomyolysis. Regular monitoring is required for long-term use, and any changes in symptoms during treatment should be consulted with a physician. This drug can interact with other medications, so if you are taking other drugs, you must inform your healthcare provider. Special caution is required when taken with antiviral agents, antibiotics, and anticoagulants. During pregnancy, no specific risks have been identified in animal studies, but it should be administered with caution in pregnant women, and it is advisable to avoid this medication while breastfeeding. As there is no specific antidote for overdose, appropriate treatment should be administered based on symptoms, and the medication should be kept out of reach of children. This drug may increase the risk of bacterial growth in the gastrointestinal tract by inhibiting gastric acid, so you should consult with your healthcare provider if gastrointestinal symptoms such as diarrhea persist. Additionally, long-term high-dose use may increase the risk of fractures, so patients with osteoporosis require regular monitoring. If any unusual symptoms such as skin rash, fever, or difficulty breathing occur during the use of this medication, immediate discontinuation and consultation with a healthcare provider are necessary.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, jaundice, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Reiter's syndrome, acute generalized exanthematous pustulosis, eosinophilia, drug reaction with systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternum pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, tachycardia, flushing, hypertension, thyroid enlargement, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremor, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, discoid lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu×2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.